Key Takeaways
- A heart centre should be selected by the patient’s pathway—acute coronary care, chronic coronary disease, valve/aortic disease, arrhythmia, heart failure, congenital disease, or surgery—not by one “cardiology” label.
- Ask what happens at 2 a.m. The emergency department, catheter laboratory, cardiac surgery, intensive care, imaging, blood bank, perfusion, and transfer system matter when an elective plan becomes unstable.
- Compare the decision before comparing the procedure. For coronary or valve disease, require a written explanation of medical, catheter-based, and surgical alternatives.
- Quality claims need a defined population, denominator, time window, complications, deaths, and follow-up. A large case count or advanced machine is not an outcome.
- Before leaving China, obtain an implant passport, images, procedure data, medicine plan, warning signs, rehabilitation prescription, and a named home clinician.
Content
The best first question is not “Which Chinese heart hospital is number one?” It is: Which door would this patient need if the condition worsened at 2 a.m., and does the elective team connect to that door?
A cardiology clinic, catheter laboratory, cardiac surgical service, electrophysiology programme, and transplant centre solve different problems. Some hospitals provide all of them at one campus; others do not. Begin by choosing the pathway.
First separate emergency care from planned travel
Do not arrange international travel for new or worsening chest pressure, breathlessness at rest, fainting, a sustained rapid or very slow heartbeat with symptoms, new weakness, shock, or suspected aortic emergency. Use immediate local emergency care. China’s national pre-hospital medical emergency number is 120 [1].
For a stable planned review, state the decision and deadline: confirm diagnosis, decide between medicines and revascularisation, compare transcatheter and surgical valve treatment, investigate an arrhythmia, evaluate advanced heart failure, or plan rehabilitation.
Choose one primary pathway
Use the following map to identify the centre’s relevant programme:
Patient problem · Core programme · Critical connected services
acute chest pain / myocardial infarction · emergency cardiology and PCI · 24-hour lab, cardiac ICU, surgery/transfer, stroke and bleeding response
stable coronary disease · coronary team · physiology/imaging, preventive cardiology, PCI and CABG comparison
valve or aortic disease · structural heart / aortic team · advanced echo/CT, surgery, anaesthesia, perfusion, rescue
rhythm disorder · electrophysiology · ambulatory monitoring, mapping, ablation, devices, anticoagulation, surgery backup
heart failure / cardiomyopathy · heart-failure programme · imaging, haemodynamics, genetics where relevant, devices, ICU, VAD/transplant pathway
congenital heart disease · congenital team · disease-specific imaging, intervention, surgery, lifelong follow-up
postoperative recovery · cardiac rehabilitation · risk stratification, exercise, medicines, nutrition, psychosocial and emergency plan
A hospital’s general cardiology reputation does not answer whether the exact pathway is mature at the exact campus.
Build a cardiac evidence packet
Send original, dated evidence rather than a diagnosis alone:
- symptom timeline, blood pressure, heart rate, oxygen saturation, weight trend, and exercise tolerance;
- ECGs and rhythm strips, not only written interpretations;
- echocardiography images and report, with measurements;
- coronary angiography or CT source images when relevant;
- cardiac MRI, nuclear imaging, vascular imaging, or catheterisation data where relevant;
- laboratory results, including kidney function, blood count, electrolytes, lipids, glucose, coagulation, troponin, and natriuretic peptides as clinically indicated;
- prior procedure reports and operative notes;
- implant manufacturer, model, serial number, date, and latest interrogation;
- current medicines, doses, adherence, allergies, and previous intolerance.
Cardiac biomarkers can support diagnosis and risk assessment, but results depend on timing and assay context [2]. Ask which studies need repeating and why; a new test should close a decision gap, not merely restart the workup.
Verify programme, clinician, and campus separately
Confirm the legal institution and practitioner through official health-authority sources. Then ask the hospital to name the current campus, responsible consultant, likely operator, covering team, and the department that owns complications.
China’s clinical-application rules require management and evaluation of cardiovascular interventional services, not just equipment [3]. Historical and current requirements emphasise institutional capability, appropriately qualified operators, case selection, severe complications, mortality, postoperative management, follow-up, and record quality [4]. Ask for present evidence; do not rely on a credential screenshot or an old training certificate.
Compare decisions, not devices
For stable coronary disease, ask the team to compare guideline-directed medical treatment, PCI, and CABG in the context of anatomy, symptoms, ischaemia, ventricular function, diabetes, renal function, bleeding risk, frailty, and the patient’s goals. Record who reviewed the source angiogram and whether intracoronary physiology or imaging would change the choice.
For valve disease, separate severity from symptoms and procedural eligibility. Ask whether a structural cardiologist, cardiac surgeon, imaging specialist, and cardiac anaesthetist reviewed the case. Compare transcatheter, surgical, and conservative approaches, including durability, anticoagulation, pacemaker risk, coronary access, reintervention, and bailout.
For arrhythmia, identify the rhythm before discussing ablation. Confirm monitoring evidence, symptom correlation, structural disease, stroke prevention, expected endpoint, mapping method, sedation, vascular access, and management of tamponade, stroke, atrio-oesophageal injury, or device infection where relevant.
For heart failure, require cause, phenotype, volume status, rhythm, coronary and valve assessment, medicines and tolerated doses, device indications, reversible factors, and trajectory. A centre that mentions transplantation should show a stepwise advanced-therapy evaluation, not present transplantation as the first answer.
Ask the 2 a.m. questions
For the exact campus and date, confirm:
- Is the relevant emergency service open 24 hours?
- Can the catheter or electrophysiology laboratory mobilise after hours?
- Is cardiac surgery on site, on call, or reached by transfer?
- Is there a cardiac ICU with the required monitoring and mechanical support?
- Are perfusion, blood bank, vascular surgery, neurology, renal replacement, and advanced imaging available when needed?
- Who accepts a deteriorating international patient before records or payment are reconciled?
- What is the written transfer pathway if the campus cannot rescue the complication?
For ventricular assist technology or heart transplantation, verify specific legal and clinical authorisation. The National Health Commission publishes qualified organ-transplant institutions and an official query service [5]. A heart-failure clinic or transplant collaboration is not the same as a licensed heart-transplant programme.
Read quality through the relevant indicator
China’s National Health Commission published cardiovascular quality-control indicators covering major disease and procedural pathways [6]. In 2025, a national specialty improvement target specifically addressed intravascular imaging for left-main PCI and called for registration of complications, deaths, and follow-up [7].
For this patient’s proposed pathway, request:
- annual eligible cases at the site and by the intended operator;
- procedural success definition;
- in-hospital and 30-day death;
- stroke, myocardial infarction, major bleeding, acute kidney injury, vascular complication, infection, reoperation, tamponade, or pacemaker rate as relevant;
- conversion or emergency surgery;
- readmission and repeat procedure;
- completeness and duration of follow-up;
- risk adjustment and exclusions.
Do not compare two percentages until their patients, definitions, and follow-up match. Ask how the programme reviews adverse events and changes practice.
Make the implant and medicine chain traceable
For a stent, valve, pacemaker, defibrillator, occluder, graft, or assist device, obtain the manufacturer, product and model, size, lot/serial or unique identifier, expiry where relevant, implant location, procedure date, operator, and MRI/airport-security conditions. China’s interventional rules require traceable device records [4].
The discharge medicine list should state generic name, dose, timing, indication, start/stop rules, missed-dose advice, interactions, and who may modify it. Antiplatelet and anticoagulant plans require particular clarity before dental work, surgery, bleeding, or long travel. Never stop them because a translated brand name is unfamiliar; contact the responsible clinician.
Treat cardiac rehabilitation as a prescription
China’s cardiovascular action plan includes secondary prevention and rehabilitation [8]. Ask for a personalised prescription covering exercise intensity, heart-rate or symptom limits, wound and lifting restrictions, blood pressure, nutrition, smoking, sleep, psychological recovery, driving, sexual activity, work, and air travel.
Confirm the rehabilitation programme’s emergency response and who adjusts medicines. A gym package, massage, or resort stay is not cardiac rehabilitation.
Price the full pathway
Request separate figures for review, repeat imaging/labs, procedure, professional fees, anaesthesia, disposables and implant, ICU, room, medicines, rehabilitation, interpreter, records, and management of predictable complications. Clarify deposits, cancellation, product substitution, refund, and insurer authorisation.
If the plan may change from catheter treatment to surgery, request both pathways and the financial rule for conversion. A low procedure quote can exclude the implant, imaging guidance, intensive care, or second intervention.
Close the handoff before flying
Collect source ECG, echo, angiography/CT/MRI, haemodynamic and EP data, procedure and operative reports, implant card, medicine reconciliation, kidney and blood results, complications, restrictions, warning signs, rehabilitation plan, and follow-up dates.
For long travel, ask about timing, mobility, oxygen, venous-thromboembolism risk, wound care, device checks, and access to medicines. A clinician at home should confirm receipt and accept responsibility. The centre is suitable only if both the 2 a.m. rescue door and the home-country handoff door are open.
Medical disclaimer: This guide provides general selection and planning information and does not rank Chinese cardiac institutions or recommend a procedure. Heart symptoms can become emergencies; seek immediate local care for severe or worsening symptoms.
Related Hospitals
List a heart centre only after verifying the legal institution, exact campus, relevant pathway, team, after-hours rescue, quality evidence, implant traceability, rehabilitation, and cross-border follow-up.
Related Treatments
Link only the medicine, PCI, surgery, valve procedure, ablation, device, VAD, or transplant pathway that matches the confirmed diagnosis, anatomy, risk, regulatory status, and written team decision.
Related Guides
- Coronary Angiography and PCI in China
- CABG in China: Choosing between Surgery and PCI
- Valve Repair, Replacement, and Transcatheter Options
- Arrhythmia Evaluation and Catheter Ablation
- Cardiac Rehabilitation after Treatment
FAQ
Is a dedicated heart hospital always better than a general hospital cardiology centre?
No. Compare the programme required by the patient and its connected rescue services. A general hospital may offer stronger support for complex noncardiac disease; a heart hospital may have greater pathway depth.
Does a high annual PCI or surgery volume prove better quality?
No. Volume is context. Compare patient risk, outcomes, complications, rescue, readmissions, and follow-up using the same definitions.
Should a surgeon and interventional cardiologist both review coronary or valve disease?
When the main options cross specialties, a documented heart-team comparison helps expose trade-offs and confirms that one procedure was not chosen simply because it was the first available service.
How can I verify a claimed heart-transplant programme?
Check the National Health Commission’s qualified organ-transplant institution list and ask the exact centre to confirm its registered transplant category, current team, evaluation pathway, and follow-up responsibility.
What cardiac records matter most when returning home?
Source imaging and signals, procedure details, haemodynamics, implant identifiers, medicine plan, complications, restrictions, warning signs, and the next decision point are more useful than a short general discharge letter.
Sources
- National Health Commission: Measures for the Administration of Pre-hospital Medical Emergency Care
- National Health Commission: Clinical Use and Quality Control of Cardiac Biomarkers
- National Health Commission: Interpretation of the 2019 Cardiovascular Interventional Technology Standards
- National Health Commission: Cardiovascular Interventional Technology Management Standard
- National Health Commission: Qualified Organ-transplant Institutions
- National Health Commission: Cardiovascular Medical Quality-control Indicators, 2021
- National Health Commission: 2025 Specialty Quality-improvement Targets, including Left-main PCI
- National Health Commission: Cardiovascular and Cerebrovascular Disease Action Plan 2023–2030
- National Medical Products Administration: Medical Device Unique Identification Database
Hero Image Prompt
Generated with the built-in image tool for this article: an unbranded heart-team decision meeting with an international patient and companion, interventional cardiology, cardiac surgery, electrophysiology, anonymised coronary angiography, echocardiography, and rhythm mapping. It does not show a real record, institution, treatment outcome, or endorsement.